Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant ‐ implications for precision dosing in a global perspective-Reference-Cited by-同舟云学术

Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant ‐ implications for precision dosing in a global perspective

Published:2022-08-05 Issue:12 Volume:88 Page:5149-5165
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Langmia Immaculate M.¹^ORCID,Just Katja S.¹^ORCID,Yamoune Sabrina¹²,Müller Julian Peter¹,Stingl Julia C.¹

Affiliation:

1. Institute of Clinical Pharmacology University Hospital of RWTH Aachen Aachen Germany

2. Federal Institute for Drugs and Medical Devices, BfArM Bonn Germany

Funder

Alexander von Humboldt-Stiftung

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15467

Reference131 articles.

1. Pharmacogenetics of Anesthesia

2. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers

3. Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective

4. A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of steroid hormone levels on estradiol‐mediated regulation of cytochrome P450 2B6 compared to 1B1 in breast cancer cells;Basic & Clinical Pharmacology & Toxicology;2024-08-21

2. Polish standard of treatment with racemic ketamine for patients with depressive disorders developed by a Working Group appointed by the National Consultant in the field of psychiatry;Psychiatria Polska;2024-06-30

3. Long‐term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co‐administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus;The FASEB Journal;2024-04-04

4. The prevalence of selected licit and illicit drugs in drug facilitated sexual assaults;2024

5. The prevalence of selected licit and illicit drugs in drug facilitated sexual assaults;Forensic Science International: Synergy;2024